This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Immunocore Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Richard Suckling: Innovator in Hepatitis B Research
Introduction
Richard Suckling is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of medical research, particularly in the area of hepatitis B. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Richard Suckling holds a patent titled "Binding Molecules Specific for HBV Envelope Protein." This patent represents a significant advancement in the understanding and treatment of hepatitis B, showcasing his commitment to improving healthcare outcomes.
Career Highlights
Richard is currently associated with Immunocore Limited, a company known for its pioneering work in immunotherapy. His role at Immunocore has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Richard has worked alongside talented colleagues, including Mary Marguerita Connolly and Sara Crespillo Torreño. These collaborations have enriched his research and expanded the impact of his innovations.
Conclusion
Richard Suckling's contributions to hepatitis B research through his patent and work at Immunocore Limited highlight his role as an influential inventor in the medical field. His dedication to innovation continues to inspire advancements in healthcare.